Improving testing for hepatitis B before treatment with rituximab

AIMS/OBJECTIVES/BACKGROUND: Individuals with current or previous infection with the hepatitis B virus (HBV) can experience viral reactivation when treated with immunosuppression. Rituximab, an anti-CD20 antibody used to treat many diseases, has potent immunosuppressant effects with a high risk of ca...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Gastroenterol Hepatol
Huvudupphovsmän: Dyson, Jessica K., Jopson, Laura, Ng, Sarah, Lowery, Matthew, Harwood, Jayne, Waugh, Sheila, Valappil, Manoj, McPherson, Stuart
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams And Wilkins 2016
Ämnen:
Original Articles: Hepatitis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5010281/
https://ncbi.nlm.nih.gov/pubmed/27388147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000000689
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk